Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate biote Corp. before investing.

In this article, we go over a few key elements for understanding biote Corp.’s stock price such as:

• biote Corp.’s current stock price and volume
• Why biote Corp.’s stock price changed recently
• Upgrades and downgrades for BTMD from analysts
• BTMD’s stock price momentum as measured by its relative strength

About biote Corp. (BTMD)

Before we jump into biote Corp.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Want to learn more about biote Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about biote Corp..

biote Corp.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, biote Corp.’s stock price was $2.250.

biote Corp. is up 1.35% from its previous closing price of $2.220.

During the last market session, biote Corp.’s stock traded between $2.220 and $2.290. Currently, there are approximately 30.65 million shares outstanding for biote Corp..

biote Corp.’s price-earnings (P/E) ratio is currently at 5.2, which is low compared to the Pharmaceuticals industry median of 20.5. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

biote Corp. Stock Price History

biote Corp.’s (BTMD) price is currently up 19.05% so far this month.

During the month of July, biote Corp.’s stock price has reached a high of $2.600 and a low of $1.870.

Over the last year, biote Corp. has hit prices as high as $4.200 and as low as $1.270. Year to date, biote Corp.’s stock is down 13.46%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused biote Corp. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there was 1 analyst who downgraded biote Corp.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate biote Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on biote Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

biote Corp.’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about biote Corp. (BTMD) by visiting AAII Stock Evaluator.

Relative Price Strength of biote Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, biote Corp. has a weighted four-quarter relative price strength of -12.60%, which translates to a Momentum Score of 20 and is considered to be Very Weak.

Want to learn more about how biote Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

biote Corp. Stock Price: Bottom Line

As of July 31, 2026, biote Corp.’s stock price is $2.250, which is up 1.35% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like biote Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.